[Frontiers in Bioscience E4, 1237-1245, January 1, 2012] |
|
|
Natural suppressor cells; past, present and future Parvin Forghani1, M.R. Khorramizadeh1, Edmund K. Waller2 1School of Public Health, Dept of Medical Biotechnology, School of Advanced Medical Technologies Tehran University of Medical Sciences, Tehran, Iran, 2Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta, GA TABLE OF CONTENTS
1. ABSTRACT Myeloid Derived Suppressor Cells (MDSCs) are a mixed group of bone marrow-derived myeloid cells containing macrophages, granulocytes, immature DCs and early myeloid precursors that have immune suppressive activity (1). MDSCs infiltrate the BM, spleen and peripheral blood of tumors-bearing experimental animals and are found in the blood of cancer patients as a result of tumor-induced alterations in myelopoiesis. Evidence from murine model systems indicated that myeloid-derived cells with suppressor activity also accumulate in non-tumor bearing hosts in response to infection, chemotherapy (2), stress (3), and immune senescence(4). MDSCs are considered key negative regulators of immune responses. Their association with tumor-associated immune defects make MDSCs an |